Presentation Information
[1-MO2-2]TAT against antibody treatment resistant peritoneal metastasis of uterine serous carcinoma
Huizi K. Li1、Mayuka Anko2、Sumitaka Hasegawa1 (1.Dept. of Charged Particle Therapy Res., QST、2.Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan)